Mh. Perrin et al., Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors, J PHARM EXP, 288(2), 1999, pp. 729-734
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The characteristics of a high-affinity antagonist radioligand are compared
with those a high-affinity agonist in binding to the cloned corticotropin-r
eleasing factor receptor type 1 (CRF-RI) and type 2 (CRF-R2) and to the nat
ive receptors that exist in rat cerebellum and brain stem. The relative pot
encies of CRF antagonists and agonists to the two types of cloned CRF recep
tors overexpressed stably in Chinese hamster ovary cells are determined usi
ng the antagonist radioligand I-125-[DTyr(1)]astressin (Ast*), and the agon
ist radioligand, I-125-[Tyr]rat urocortin (Ucn*). The inhibitory binding co
nstants (K-i) of astressin and urocortin are 1 to 2 nM for all receptors an
d are independent of which radioligand is employed. Astressin binds with hi
gh affinity to the native cerebellar/brain stem receptor and relative poten
cies of selected CRF analogs determined with Ast* on the native receptor ar
e similar to those obtained for the cloned CRF-R1. The specific binding of
Ast* to endogenous brain receptors is greater than that of Ucn*, resulting
in more sites being detected by the antagonist than by the agonist. In cont
rast to another CRF agonist, the binding of Ucn* to the cloned receptors is
relatively insensitive to guanyl nucleotides at both 20 degrees C and 37 d
egrees C; however, its binding to the native receptor is displaced by guany
l nucleotides at 37 degrees C and, to a lesser degree, at 20 degrees C. As
expected, the binding of the antagonist Ast* is not affected by guanyl nucl
eotides. Because it is a high-affinity, specific CRF antagonist, astressin
is eminently suitable as a ligand for detection and characterization of bot
h endogenous and cloned CRF receptors.